We’re thrilled to share exciting news from METAvivor: we have received 195 Letters of Intent (LOIs) for our 2025 metastatic breast cancer (MBC) research grant cycle — nearly double the number we typically receive in a given year.
Gloria Echeverria, PhD, a former METAvivor Research Award grantee, shares her thoughts on the current challenges researchers are facing due to funding cuts.
